Alterity Therapeutics annual depreciation and amortization
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Alterity Therapeutics Depreciation & Amortization Growth & History (ATHE)
Alterity Therapeutics's depreciation and amortization was $28,307 for fiscal 2025.
View full Alterity Therapeutics company overviewAlterity Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $28,307 | −$7,037 | −19.91% |
| 2024 | 2024-06-30 | $35,344 | −$2,510 | −6.63% |
| 2023 | 2023-06-30 | $37,854 | $20,006 | +112.09% |
| 2022 | 2022-06-30 | $17,848 | −$814 | −4.36% |
| 2021 | 2021-06-30 | $18,662 | −$7,326 | −28.19% |
| 2020 | 2020-06-30 | $25,988 | −$3,708 | −12.49% |
| 2019 | 2019-06-30 | $29,696 | $7,897 | +36.23% |
| 2018 | 2018-06-30 | $21,799 | $471 | +2.21% |
| 2017 | 2017-06-30 | $21,328 | −$1,482 | −6.50% |
| 2016 | 2016-06-30 | $22,810 | — | — |
Alterity Therapeutics depreciation and amortization trends
Over the last five fiscal years, Alterity Therapeutics's depreciation and amortization increased from $25,988 to $28,307, a change of $2,319.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alterity Therapeutics source filings ↗